Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition. | Exp Hematol Oncol | 2026 | 41645323 | PubTator, text mining | PubMed |
| Large-scale mouse mutagenesis identifies novel genes affecting vertebral anatomy. | Mamm Genome | 2026 | 41644829 | PubTator, text mining | PubMed |
| Integrating single-nucleus barcoding with spatial transcriptomics via Stamp-seq to reveal immunotherapy response-enhancing functional modules in NSCLC. | Cell Discov | 2026 | 41644517 | PubTator, text mining | PubMed |
| An in vivo and in vitro spatiotemporal profile of human midbrain development. | Nat Commun | 2026 | 41633979 | PubTator, text mining | PubMed |
| Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. | J Immunother Cancer | 2026 | 41629132 | PubTator, text mining | PubMed |
| Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report. | Am J Case Rep | 2026 | 41606966 | PubTator, text mining | PubMed |
| Targeting cancer stem cells as the most aggressive and tumor-initiating cells. | Transl Oncol | 2026 | 41604836 | PubTator, text mining | PubMed |
| FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. | Acta Neuropathol | 2026 | 41591566 | PubTator, text mining | PubMed |
| The Role of Interferon-γ-Induced Granzyme B in Enhancing Antitumour Immune Responses in Oral Squamous Cell Carcinoma. | Int Dent J | 2026 | 41576732 | PubTator, text mining | PubMed |
| Features of the spatial organization and qualitative composition of the collagen matrix in prostate cancer. | J Mol Histol | 2026 | 41553564 | PubTator, text mining | PubMed |
| An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. | J Immunother Cancer | 2026 | 41539687 | PubTator, text mining | PubMed |
| LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein. | Cell Mol Life Sci | 2026 | 41535615 | PubTator, text mining | PubMed |
| A mechanomimetic model of skin fibrosis. | Lab Chip | 2026 | 41521965 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis identifies genetic risk loci for mono- and polyneuropathies in 983 477 individuals. | Hum Mol Genet | 2026 | 41518141 | PubTator, text mining | PubMed |
| Proteomic mapping of human Tenon's fascia reveals its biomimetic potential for corneal stromal extracellular matrix reconstruction. | Exp Eye Res | 2026 | 41478390 | PubTator, text mining | PubMed |
| Discovery of novel candidate genes for congenital diaphragmatic hernia via whole exome sequencing. | Pediatr Int | 2026 | 41454640 | PubTator, text mining | PubMed |
| Rotating magnetic field downregulating type XI collagen to suppress triple-negative breast cancer metastasis by inactivating the ITGB1/FAK/YAP signaling pathway. | Int J Biol Macromol | 2026 | 41391796 | PubTator, text mining | PubMed |
| The role of collagen pathologies and ligamentous laxity in lumbar disc herniation and its recurrence: a systematic review and meta-analysis. | J Clin Neurosci | 2026 | 41370992 | PubTator, text mining | PubMed |
| Axial length, myopia progression, and myopic maculopathy in Stickler syndrome. | Acta Ophthalmol | 2026 | 41250836 | PubTator, text mining | PubMed |
| Modeling hepatic fibrosis in TP53 knockout iPSC-derived human liver organoids. | Mol Oncol | 2026 | 41065540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=4